In vitro biotransformation of atrazine by rat liver microsomal cytochrome P450 enzymes

Chemico-Biological Interactions

Volumn 116, Issue 3, 1998, Pages 181-198

  Hanioka, Nobumitsu ^a   Jinno, Hideto ^a   Kitazawa, Ken ^b   Tanaka Kagawa, Toshiko ^a   Nishimura, Tetsuji ^a   Ando, Masanori ^a   Ogawa, Kunihiko ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Atrazine; Atrazine biotransformation; Cytochrome P450; Cytochrome P450 isoforms; Rat liver microsomes

Indexed keywords

ATRAZINE; BUFURALOL; CIMETIDINE; CYTOCHROME P450; HERBICIDE; METYRAPONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSFORMATION; FEMALE; IN VITRO STUDY; KINETICS; LIVER MICROSOME; MALE; MICHAELIS MENTEN KINETICS; NONHUMAN; RAT; REVIEW; SEX DIFFERENCE; TOXICITY;

EID: 0031782327     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00086-6     Document Type: Article

References (50)

1. US Environmental Protection Agency, Atrazine, in: Drinking Water Health Advisory: Pesticides, Lewis Publishers, Chelsea, 1991, pp. 43-67.
2. Stevens J.T., Sumner D.D. Herbicides. Hayes W.J., Laws E.R. Handbook of Pesticide Toxicology. 3:1991;1317-1408 Academic Press, New York.
3. Frank R., Sirons G.J. Dissipation of atrazine residues from soils. Bull. Environ. Contam. Toxicol. 34:1985;541-548.
4. Ritter W.F. Pesticide contamination of ground water in the United States. J. Environ. Sci. Health B. 15:1990;1-29.
5. Frank R., Logan L., Clegg B.S. Pesticide and polychlorinated biphenyl residues in waters at the mouth of the Grand, Saugeen, and Thames Rivers, Ontario, Canada. Arch. Environ. Contam. Toxicol. 21:1991;585-595.
6. Balinova A. Solid-phase extraction followed by high-performance liquid chromatographic analysis for monitoring herbicides in drinking water. J. Chromatogr. 643:1993;203-207.
7. Molinari G.P., Fontana G., Carrara G. Evaluation of herbicide migration from water to gorgonzola and mozzarella cheeses in industrial processing. Food Addit. Contam. 12:1995;195-201.
8. Eldridge J.C., Tennant M.K., Wetzel L.T., Breckenridge C.B., Stevens J.T. Factors affecting mammary tumor incidence in chlorotriazine-treated female rats: hormonal properties, dosage, and animal strain. Environ. Health Perspect. 102:1994;29-36.
9. Wetzel L.T., Luempert III L.G., Breckenridge C.B., Tisdel M.O., Stevens J.T., Thakur A.K., Extrom P.J., Eldridge J.C. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health. 43:1994;169-182.
10. Bakke J.E., Larson J.D., Price C.E. Metabolism of atrazine and 2-hydroxyatrazine by the rat. J. Agric. Food Chem. 20:1972;602-607.
11. Gojmerac T., Kniewald J. Atrazine biodegradation in rats: a model for mammalian metabolism. Bull. Environ. Contam. Toxicol. 43:1989;199-206.
12. Adams N.H, Levi P.E, Hodgson E. In vitro studies of the metabolism of atrazine, simazine, and terbutryn in several vertebrate species. J. Agric. Food Chem. 38:1990;1411-1417.
13. Lang D., Criegee D., Grothusen A., Saalfrank R.W., Böcker R.H. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans. Drug Metab. Dispos. 24:1996;859-865.
14. Dauterman W.C., Muecke W. In vitro metabolism of atrazine by rat liver. Pesticide Biochem. Physiol. 4:1974;212-219.
15. Guddewar M.B., Dauterman W.C. Studies of a glutathione S-transferase preparation from mouse liver which conjugates chloro-s-triazine herbicides. Pesticide Biochem. Physiol. 12:1979;1-9.
16. Fenner-Crisp P.A. Endocrine disruptor risk characterization: an EPA perspective. Regul. Toxicol. Pharmacol. 26:1997;70-73.
17. Golden R.J., Noller K.L., Titus-Ernstoff L., Kaufman R.H., Mittendorf R., Stillman R., Reese E.A. Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit. Rev. Toxicol. 28:1998;109-227.
18. Tennant M.K., Hill D.S., Eldridge J.C., Wetzel L.T., Breckenridge C.B., Stevens J.T. Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. J. Toxicol. Environ. Health. 43:1994;197-211.
19. Tran D.Q., Kow K.Y., McLachlan J.A., Arnold S.F. The inhibition of estrogen receptor-mediated responses by chloro-S-triazine-derived compounds is dependent on estradiol concentration in yeast. Biochem. Biophys. Res. Commun. 227:1996;140-146.
20. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42:1982;4875-4917.
21. Souček P., Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica. 22:1992;83-103.
22. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40:1989;243-288.
23. Ryan D.E., Levin W. Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45:1990;153-239.
24. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:1964;2370-2378.
27. Laemmli U.K. Cleavage of structual proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
29. Buening M.K., Franklin M.R. The formation of complexes absorbing at 455 nm from cytochrome P-450 and metabloites of compounds related to SKF 525-A. Drug Metab. Dispos. 2:1974;386-390.
30. Murray M., Reidy G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42:1990;85-101.
31. Fuhr U., Doehmer J., Battula N., Wolfel C., Kudla C., Keita Y., Staib A.H. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochem. Pharmacol. 43:1992;225-235.
32. Eagling V.A., Tjia J.F., Back D.J. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br. J. Clin. Pharmacol. 45:1998;107-114.
33. Funae Y., Imaoka S. Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats. Biochim. Biophys. Acta. 926:1987;349-358.
34. Lunetta J.M., Sugiyama K., Correia M.A. Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal. Mol. Pharmacol. 35:1989;10-17.
35. Chang T., Levine M., Bellward G.D. Selective inhibition of rat hepatic microsomal cytochrome P-450: II. Effect of the in vitro administration of cimetidine. J. Pharmacol. Exp. Ther. 260:1992;1450-1455.
36. Mimura M., Yamazaki H., Sugahara C., Hiroi T., Funae Y., Shimada T. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Biochem. Pharmacol. 47:1994;1957-1963.
37. Wan J., Imaoka S., Chow T., Hiroi T., Yabusaki Y., Funae Y. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Arch. Biochem. Biophys. 348:1997;383-390.
38. Brady J.F., Ishizaki H., Fukuto J.M., Lin M.C., Fadel A, Gapac J.M., Yang C.S. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 4:1991;642-647.
39. Hammond D.K., Bjercke R.J., Langone J.J., Strobel H.W. Metabolism of nicotine by rat liver cytochromes P-450: Assessment utilizing monoclonal antibodies to nicotine and cotinine. Drug Metab. Dispos. 19:1991;804-808.
40. Nakayama H, Okuda H, Nakashima T, Imaoka S, Funae Y. Nicotine metabolism by rat hepatic cytochrome P450s. Biochem. Pharmacol. 45:1993;2554-2556.
41. Sonderfan A.J., Arlotto M.P., Dutton D.R., McMillen S.K., Parkinson A. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 255:1987;27-41.
42. Larrey D., Tinel M., Pessayre D. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochem. Pharmacol. 32:1983;1487-1493.
43. Shiiyama S., Soejima-Ohkuma T., Honda S., Kumagai Y., Cho A.K., Yamada H., Oguri K., Yoshimura H. Major role of the CYP2C isozymes in deamination of amphetamine and benzphetamine: evidence for the quinidine-specific inhibition of the reactions catalysed by rabbit enzyme. Xenobiotica. 27:1997;379-387.
44. Gibson G.G., Orton T.C., Tamburini P.P. Cytochrome P-450 induction by clofibrate: purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem. J. 203:1982;161-168.
45. Amet Y., Berthou F., Goasduff T., Salaun J.P., Le-Breton L., Menez J.F. Evidence that cytochrome P450 2E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Commun. 203:1994;1168-1174.
46. Bradway D.E., Moseman R.F. Determination of urinary residue levels of the N-dealkyl metabolites of triazine herbicides. J. Agric. Food Chem. 30:1982;244-247.
47. Waxman D.J., Dannan G.A., Guengerich F.P. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry. 24:1985;4409-4417.
48. Hanioka N., Jinno H., Tanaka-Kagawa T., Nishimura T., Ando M. Changes in rat liver cytochrome P450 enzymes by atrazine and simazine treatment. Xenobiotica. 28:1998;683-698.
49. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:1997;205-212.
50. Ramamoorthy K., Wang F., Chen I.C., Norris J.D., McDonnell D.P., Leonard L.S., Gaido K.W., Bocchinfuso W.P., Korach K.S., Safe S. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology. 138:1997;1520-1527.